- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neoplasm, Residual in United States
Total 49489 results
-
M.D. Anderson Cancer CenterSuspended
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnAcute Myeloid Leukemia | Minimal Residual Disease NegativityUnited States
-
University of LeicesterActive, not recruitingCancerUnited Kingdom
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of Maryland, BaltimoreActive, not recruitingMixed Phenotype Acute Leukemia (MPAL) | Measurable Residual Disease (MRD)United States
-
Abramson Cancer Center at Penn MedicineRecruitingBreast CancerUnited States
-
EnteromeCompletedColorectal CancerUnited States
-
M.D. Anderson Cancer CenterTaihoRecruitingColorectal CancerUnited States
-
M.D. Anderson Cancer CenterBellicum Pharmaceuticals, Inc.Not yet recruitingColorectal Cancer | Minimal Residual DiseaseUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Cancer | Colon CancerUnited States
-
Washington University School of MedicineTaiho Oncology, Inc.RecruitingMyelodysplastic SyndromesUnited States
-
Memorial Sloan Kettering Cancer CenterPfizerWithdrawnAcute Myeloid Leukemia (AML) | Minimal Residual DiseaseUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Personalis Inc.RecruitingMinimal Residual Disease | TNBC - Triple-Negative Breast CancerUnited States
-
Lumicell, Inc.National Cancer Institute (NCI)Completed
-
UNC Lineberger Comprehensive Cancer CenterActive, not recruitingLeukemia, Myeloid, Acute | Minimal Residual DiseaseUnited States
-
University of WashingtonPfizerRecruitingAcute Myeloid LeukemiaUnited States
-
Roswell Park Cancer InstituteRecruitingColorectal Cancer | Metastatic Unresectable Sarcoma | Metastatic Malignant Neoplasm in the Lung | Resectable Sarcoma | Metastatic Soft Tissue Sarcoma | Metastatic Bone SarcomaUnited States
-
AmgenTerminatedMyelodysplastic Syndrome | Relapsed/Refractory AML | Minimal Residual Disease Positive AMLUnited States, Canada, Germany, Netherlands
-
Jonsson Comprehensive Cancer CenterStemline Therapeutics, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
University of FloridaCelgene CorporationTerminatedMyelodysplastic Syndromes | Leukemia, MyeloidUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease PersistenceUnited States
-
University of California, IrvineNatera, Inc.; Taiho Pharmaceutical Co., Ltd.RecruitingColorectal Cancer | Colon AdenocarcinomaUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
University of PennsylvaniaTerminatedLeukemia, Acute LymphoblasticUnited States
-
M.D. Anderson Cancer CenterBreakThrough TherapeuticsCompletedChronic Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemiaUnited States
-
Boston Medical CenterCompleted
-
Dana-Farber Cancer InstituteGenentech, Inc.; Stand Up To CancerActive, not recruitingBreast Cancer | Triple Negative Breast Cancer | Circulating Tumor DNA | Residual CancerUnited States
-
Hoffmann-La RocheNSABP Foundation Inc; German Breast GroupActive, not recruitingBreast CancerUnited States, Italy, United Kingdom, Canada, Czechia, Argentina, Austria, Belgium, Brazil, China, France, Germany, Guatemala, Ireland, Panama, Spain, Sweden, Taiwan, Turkey, Colombia, Hong Kong, Peru, Switzerland, South Africa, Israel, G... and more
-
Masonic Cancer Center, University of MinnesotaWithdrawnAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
Exact Sciences CorporationNSABP Foundation IncRecruitingColorectal CancerUnited States
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States
-
University of RochesterRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
NorthShore University HealthSystemTerminatedPostoperative Residual Neuromuscular BlockadeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyRecruitingAcute Lymphoblastic Leukemia | B-Cell Lymphoblastic LeukemiaUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDiurnal Residual Limb Fluid Volume FluctuationUnited States
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Medical College of WisconsinRecruiting
-
University of Illinois at ChicagoRecruiting
-
University of Illinois at ChicagoRecruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Mayo ClinicRecruitingBreast Cancer | ResidualUnited States
-
University of Colorado, DenverRecruitingPostoperative Residual Curarization | Kidney Transplant; Complications | Postoperative Residual WeaknessUnited States
-
Beth Israel Deaconess Medical CenterCompletedPostoperative Respiratory Complication | Residual Neuromuscular Blockade | Curarization, Postoperative ResidualUnited States
-
NorthShore University HealthSystemCompletedResidual Neuromuscular Blockade in Elderly PatientsUnited States
-
Eastern Cooperative Oncology GroupJanssen, LPRecruitingT-cell Acute Lymphoblastic LeukemiaUnited States
-
Sumithira VasuCompletedRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Recurrent Adult Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Minimal Residual DiseaseUnited States